Original Article
Author Details :
Volume : 9, Issue : 1, Year : 2023
Article Page : 44-48
https://doi.org/10.18231/j.ijced.2023.007
Abstract
Background and Aims: HIV patients frequently have mucocutaneous manifestations, which could be the first sign of the infection and can also be prognostic markers for disease progression. This study was done to note the different mucocutaneous manifestations occurring in the people living with HIV/AIDS.
Materials and Methods : One hundred ensuent HIV seropositive patients who attended the opd were included in the study.
Results: The bulk of the study participants were illiterate, had a mean age of 32, and a male to female ratio of 2:1. The patients' number of manifestations ranged from 01 to 05. The most typical illnesses observed in this investigation were dermatophyte infections followed by oral candidiasis. The most frequent non-infectious symptoms observed in this investigation were SD and PPE. The most prevalent STI was herpes genitalis. Inversely correlated with CD4 level were the type, number, and severity of mucocutaneous symptoms. The number of manifestations and CD4 count were found to be inversely correlated.
Conclusion: The majority of PLHAs (55%) exhibited several manifestations. The majority of the manifestations are unusual, persistent, recurrent, and resistant to the therapy. Young patients presenting with extensive SD, PPE, OC, scrofuloderma, and HZ should encourage the clinician to investigate the patient's sero-reactivity status
Keywords: Cutaneous manifestations, HIV/AIDS, STI's, CD4 count, MSM, PLHA
How to cite : Nookala S S, Panthalla V L, Kommala P, Study of mucocutaneous manifestations in HIV-infected patients and its relation to cd4 count and stage of HIV disease. IP Indian J Clin Exp Dermatol 2023;9(1):44-48
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Received : 24-02-2023
Accepted : 11-03-2023
Viewed: 689
PDF Downloaded: 268